134 related articles for article (PubMed ID: 9481497)
1. Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging.
Hollinger EF; Alibazoglu H; Ali A; Green A; Lamonica G
Clin Nucl Med; 1998 Feb; 23(2):93-8. PubMed ID: 9481497
[TBL] [Abstract][Full Text] [Related]
2. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.
Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H
Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658
[TBL] [Abstract][Full Text] [Related]
3. Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.
Sugawara Y; Fisher SJ; Zasadny KR; Kison PV; Baker LH; Wahl RL
J Clin Oncol; 1998 Jan; 16(1):173-80. PubMed ID: 9440740
[TBL] [Abstract][Full Text] [Related]
4. Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results.
Sugawara Y; Zasadny KR; Kison PV; Baker LH; Wahl RL
J Nucl Med; 1999 Sep; 40(9):1456-62. PubMed ID: 10492365
[TBL] [Abstract][Full Text] [Related]
5. [Splenic and bone marrow increased 18F-FDG uptake in a PET scan performed following treatment with G-CSF].
Ruiz-Hernández G; Scaglione C; Delgado-Bolton RC; Gutiérrez-García A; Madero L; Jiménez-Vicioso A; Carreras-Delgado JL
Rev Esp Med Nucl; 2004; 23(2):124-6. PubMed ID: 15000944
[TBL] [Abstract][Full Text] [Related]
6. Optimizing the interval between G-CSF therapy and F-18 FDG PET imaging in children and young adults receiving chemotherapy for sarcoma.
Trout AT; Sharp SE; Turpin BK; Zhang B; Gelfand MJ
Pediatr Radiol; 2015 Jul; 45(7):1001-6. PubMed ID: 25646737
[TBL] [Abstract][Full Text] [Related]
7. Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin.
Blodgett TM; Ames JT; Torok FS; McCook BM; Meltzer CC
Clin Nucl Med; 2004 Mar; 29(3):161-3. PubMed ID: 15162984
[TBL] [Abstract][Full Text] [Related]
8. Fluorodeoxyglucose uptake in the bone marrow after granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma.
Hanaoka K; Hosono M; Usami K; Tatsumi Y; Yamazoe Y; Komeya Y; Tsuchiya N; Ishii K; Sumita M
Nucl Med Commun; 2011 Aug; 32(8):678-83. PubMed ID: 21499162
[TBL] [Abstract][Full Text] [Related]
9. Diffuse bone marrow uptake on F-18 FDG PET in patients with myelodysplastic syndromes.
Inoue K; Okada K; Harigae H; Taki Y; Goto R; Kinomura S; Kato S; Kaneta T; Fukuda H
Clin Nucl Med; 2006 Nov; 31(11):721-3. PubMed ID: 17053396
[TBL] [Abstract][Full Text] [Related]
10. (18)F-FDG-PET/CT findings of granulocyte colony stimulating factor (G-CSF)-producing lung tumors.
Morooka M; Kubota K; Murata Y; Shibuya H; Ito K; Mochizuki M; Akashi T; Chiba T; Nomura T; Ito H; Morita T
Ann Nucl Med; 2008 Aug; 22(7):635-9. PubMed ID: 18756367
[TBL] [Abstract][Full Text] [Related]
11. Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow.
Kazama T; Swanston N; Podoloff DA; Macapinlac HA
Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1406-11. PubMed ID: 16133379
[TBL] [Abstract][Full Text] [Related]
12. Fluorine-18 fluorodeoxyglucose splenic uptake from extramedullary hematopoiesis after granulocyte colony-stimulating factor stimulation.
Abdel-Dayem HM; Rosen G; El-Zeftawy H; Naddaf S; Kumar M; Atay S; Cacavio A
Clin Nucl Med; 1999 May; 24(5):319-22. PubMed ID: 10232468
[TBL] [Abstract][Full Text] [Related]
13. Diffusely increased F-18 FDG uptake in bone marrow in a patient with acute anemia and recent erythropoietin therapy.
Plantade A; Montravers F; Selle F; Izrael V; Talbot JN
Clin Nucl Med; 2003 Sep; 28(9):771-2. PubMed ID: 12973005
[TBL] [Abstract][Full Text] [Related]
14. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
[TBL] [Abstract][Full Text] [Related]
15. FDG uptake by the bone marrow in NSCLC patients is related to TGF-beta but not to VEGF or G-CSF serum levels.
Van de Wiele C; VandeVyver F; Debruyne C; Philippé J; van Meerbeeck JP
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):519-22. PubMed ID: 18034241
[TBL] [Abstract][Full Text] [Related]
16. [Transitory increase in splenic FDG uptake secondary to the administration of granulocyte colony stimulating factor (G-CSF)].
Ubieto MA; Banzo J
Rev Esp Med Nucl; 2009; 28(1):36. PubMed ID: 19232179
[No Abstract] [Full Text] [Related]
17. Granulocyte Colony-Stimulating Factor Administration at 1 Hour Before 18F-FDG PET Does Not Increase Bone Marrow FDG Accumulation.
Kawabata K; Hosono M; Tanaka H; Hyuga M; Kanagaki M
Clin Nucl Med; 2021 Sep; 46(9):770-771. PubMed ID: 33883491
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET/CT Imaging of G-CSF-Producing Dedifferentiated Liposarcoma.
Eizuru Y; Nakajo M; Nakajo M; Shinohara N; Yoshiura T
Clin Nucl Med; 2022 Jan; 47(1):e98-e100. PubMed ID: 34183499
[TBL] [Abstract][Full Text] [Related]
19. Inhomogeneous bone marrow uptake caused by G-CSF mimics multiple bone metastases on FDG-PET.
Nakamoto Y; Suga T; Hara T; Ishizu K; Togashi K
Clin Nucl Med; 2010 Feb; 35(2):74-6. PubMed ID: 20090448
[TBL] [Abstract][Full Text] [Related]
20. Interaction of colony-stimulating factors and fluorodeoxyglucose f(18) positron emission tomography.
Mayer D; Bednarczyk EM
Ann Pharmacother; 2002 Nov; 36(11):1796-9. PubMed ID: 12398579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]